Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study.
Journal
Pain
ISSN: 1872-6623
Titre abrégé: Pain
Pays: United States
ID NLM: 7508686
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
pubmed:
17
10
2018
medline:
27
6
2019
entrez:
17
10
2018
Statut:
ppublish
Résumé
The objective of this study was to investigate whether incident opioid use is associated with an increased risk of hip fractures among community-dwelling persons with Alzheimer disease (AD) and to assess the association in terms of duration of use and opioid strength. Among community-dwelling persons with AD diagnosed in 2010 to 2011 (N = 23,100), a matched cohort study comparing incident opioid users (N = 4750) with opioid nonusers (N = 4750) was constructed. Matching was based on age, sex, and time since AD diagnosis at opioid initiation. Data on drug use and hip fractures were retrieved from nationwide registers. Incident opioid users were identified with a 1-year washout. Cox proportional hazard models compared the risk of hip fracture between opioid use and nonuse, and were weighted with inverse probability of treatment (IPT), based on a propensity score. Age-adjusted incidence rate of hip fractures was 3.47 (95% confidence interval [CI] 2.62-4.33) during opioid use and 1.94 (95% CI 1.65-2.22) during nonuse. Opioid use was associated with an increased risk of hip fracture (IPT-weighted hazard ratio [HR] 1.96, 95% CI 1.27-3.02). The risk was observed during the first 2 months of use (IPT-weighted HR 2.37, 1.04-5.41) and attenuated after that. The results suggest an increase in the risk of hip fracture by increasing opioid strength; weak opioids IPT-weighted HR 1.75 (0.91-3.35), buprenorphine IPT-weighted HR 2.10 (1.41-3.13), and strong opioids IPT-weighted HR 2.89 (1.32-6.32). Further research is needed to find out whether the risk of injurious falls is avoidable by slow titration of opioid doses in the beginning of treatment.
Identifiants
pubmed: 30325873
doi: 10.1097/j.pain.0000000000001412
pii: 00006396-201902000-00015
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
417-423Références
Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, Knaggs R, Martin D, Sampson L, Schofield P; Geriatric Society British. Guidance on the management of pain in older people. Age Ageing 2013;42(suppl 1):i1–57.
Coluzzi F, Mattia C, Raffa RR, Pergolizzi J. The unsolved case of bone-impairing analgesics: the endocrine effects of opioids on bone metabolism. Ther Clin Risk Manag 2015;11:515.
Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, Ballard C. Assessment and treatment of pain in people with dementia. Nat Rev Neurol 2012;8:264–74.
Dhingra L, Ahmed E, Shin J, Scharaga E, Magun M. Cognitive effects and sedation. Pain Med 2015;16:S37–43.
Fargo K; Alzheimer's Association Report. 2014 Alzheimers disease facts and figures. Alzheimer's Dement 2014;10:e47–92.
Friedman SM, Mendelson DA. Epidemiology of fragility fractures. Clin Geriatr Med 2014;30:175–81.
Gerlach LB, Olfson M, Kales HC, Maust DT. Opioids and other central nervous system–active polypharmacy in older adults in the United States. J Am Geriatr Soc 2017;65:2052–6.
Hamina A, Taipale H, Tanskanen A, Tolppanen AM, Karttunen N, Pylkkänen L, Tiihonen J, Hartikainen S. Long-term use of opioids for non-malignant pain among community-dwelling persons with and without Alzheimer's disease in Finland. PAIN 2017;158:252–60.
Hamina A, Taipale H, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease. Eur J Pain 2017;21:658–67.
Hunt LJ, Covinsky KE, Yaffe K, Stephens CE, Miao Y, Boscardin J, Smith AK. Pain in community-dwelling older adults with dementia: results from the National Health and Aging Trends Study. J Am Geriatr Soc 2015;63:1503–11.
Jensen-Dahm C, Gasse C, Astrup A, Mortensen PB, Waldemar G. Frequent use of opioids in patients with dementia and nursing home residents: a study of the entire elderly population of Denmark. Alzheimers Dement 2014;11:691–699.
Kress HG. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain 2009;13:219–30.
Li L, Setoguchi S, Cabral H, Jick S. Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database. Am J Epidemiol 2013;178:559–69.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984;34:939–44.
Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999;15:15–28.
van Ojik AL, Jansen PAF, Brouwers JRBJ, van Roon EN. Treatment of chronic pain in older people. Drugs Aging 2012;29:615–25.
Ping F, Wang Y, Wang J, Chen J, Zhang W, Zhi H, Liu Y. Opioids increase hip fracture risk: a meta-analysis. J Bone Miner Metab 2016;35:289–97.
Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158:915–20.
Saunders KW, Dunn KM, Merrill JO, Sullivan M, Weisner C, Braden JB, Psaty BM, Von Korff M. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med 2010;25:310–15.
Seppala LJ, van de Glind EMM, Daams JG, Ploegmakers KJ, de Vries M, Wermelink AM, van der Velde N. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc 2018;19:372.e1–372.e8.
Seppala LJ, Wermelink AM, de Vries M, Ploegmakers KJ, van de Glind EM, Daams JG, van der Velde N. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc 2018;19:372.e1–372.e8.
Sund R, Nurmi-Lüthje I, Lüthje P, Tanninen S, Narinen A, Keskimäki I. Comparing properties of audit data and routinely collected register data in case of performance assessment of hip fracture treatment in Finland. Methods Inf Med 2007;46:558–66.
Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. Drug exposure in register-based research—an expert-opinion based evaluation of methods. PLoS One 2017;12:e0184070.
Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. From prescription drug purchases to drug use periods—a second generation method (PRE2DUP). BMC Med Inform Decis Mak 2015;15:21.
Teng Z, Zhu Y, Wu F, Zhu Y, Zhang X, Zhang C, Wang S, Zhang L. Opioids contribute to fracture risk: a meta-analysis of 8 cohort studies. PLoS One 2015;10:1–13.
Tolppanen AM, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study. BMJ Open 2016;6:e012100.
Tolppanen AM, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease—exposure-matched cohort study. BMC Geriatr 2016;16:204.
Trifirò G, Spina E. Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems. Curr Drug Metab 2011;12:611–20.
de Vries M, Seppala LJ, Daams JG, van de Glind EMM, Masud T, van der Velde N. Fall-risk-increasing drugs: a systematic review and meta-analysis: I. Cardiovascular drugs. J Am Med Dir Assoc 2018;19:371.e1–371.e9.
WHO Collaborating Centre for Drug Statistics Methodology, 2018. The anatomical therapeutic chemical classification system. Available at (http://www.whocc.no/atc_ddd_index/). Accessed May 22, 2018.
Wright RM, Roumani YF, Boudreau R, Newman AB, Ruby CM, Studenski SA, Shorr RI, Bauer DC, Simonsick EM, Hilmer SN, Hanlon JT. Impact of central nervous system (CNS) medication use on cognition decline in community dwelling older adults: findings from the health, aging and body composition study. J Am Geriatr Soc 2009;57:243–50.
Young-McCaughan S, Miaskowski C. Definition of and mechanism for opioid-induced sedation. Pain Manag Nurs 2001;2:84–97.